Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production
Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production
The n-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) may reduce low-grade inflammation associated with obesity. The relationship between therapeutic response to n-3 PUFAs and modification of the transcriptome in obesity or metabolic syndrome remains to be explored.
Blood samples were obtained from women with obesity before and after three-months supplementation with a moderate dose of n-3 PUFAs (1.8 g EPA + DHA per day) or from controls. n-3 PUFAs (GC) and plasma concentrations of lipoxins, resolvins, protectin X (GC-MS/MS) and inflammatory markers (ELISA) were measured. Whole blood transcriptome was assayed using microarray.
Women supplemented with n-3 PUFAs for 3 months had significantly higher levels of EPA and DHA in plasma phosphatidylcholine. n-3 PUFA supplementation, in contrast to placebo, significantly decreased the concentrations of several inflammatory markers (SELE, MCP-1, sVCAM-1, sPECAM-1, and hsCRP), fasting triglycerides and insulin and increased the concentrations of pro-resolving DHA derivatives in plasma. The microarray data demonstrated effects of n-3 PUFAs on PPAR-?, NRF2 and NF-?B target genes.
N-3 PUFAs increased DHA-derived pro-resolving mediators in women with obesity. Elevated resolvins and up-regulation of the resolvin receptor occurred in parallel with activation of PPAR-? target genes related to lipid metabolism and of NRF2 up-regulated antioxidant enzymes.
1746-1755
Polus, A.
b2ba5553-cc38-4676-802b-2fcc658775a7
Zapala, B.
0abd3ca0-e4b8-40a3-b24a-6fdadb821222
Razny, U.
be94bd59-7f4a-4056-8cd5-3d7f38fc352f
Gielicz, A.
bcbb2154-ed97-41de-ab9c-268d610e953e
Kiec-Wilk, B.
c1388090-177d-48b2-a4b4-223761f8a617
Malczewska-Malec, M.
a0dac295-abb2-4429-953d-fdf03e7a9eff
Sanak, M.
e6bbd98c-9d96-4146-9347-ac9d128b69ab
Childs, C.E.
ea17ccc1-2eac-4f67-96c7-a0c4d9dfd9c5
Calder, P.C.
1797e54f-378e-4dcb-80a4-3e30018f07a6
Dembinska-Kiec, A.
9ccc5a86-29a5-45ca-b191-44912f1d90e0
12 August 2016
Polus, A.
b2ba5553-cc38-4676-802b-2fcc658775a7
Zapala, B.
0abd3ca0-e4b8-40a3-b24a-6fdadb821222
Razny, U.
be94bd59-7f4a-4056-8cd5-3d7f38fc352f
Gielicz, A.
bcbb2154-ed97-41de-ab9c-268d610e953e
Kiec-Wilk, B.
c1388090-177d-48b2-a4b4-223761f8a617
Malczewska-Malec, M.
a0dac295-abb2-4429-953d-fdf03e7a9eff
Sanak, M.
e6bbd98c-9d96-4146-9347-ac9d128b69ab
Childs, C.E.
ea17ccc1-2eac-4f67-96c7-a0c4d9dfd9c5
Calder, P.C.
1797e54f-378e-4dcb-80a4-3e30018f07a6
Dembinska-Kiec, A.
9ccc5a86-29a5-45ca-b191-44912f1d90e0
Polus, A., Zapala, B., Razny, U., Gielicz, A., Kiec-Wilk, B., Malczewska-Malec, M., Sanak, M., Childs, C.E., Calder, P.C. and Dembinska-Kiec, A.
(2016)
Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1861 (11), .
(doi:10.1016/j.bbalip.2016.08.005).
(PMID:27531277)
Abstract
The n-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) may reduce low-grade inflammation associated with obesity. The relationship between therapeutic response to n-3 PUFAs and modification of the transcriptome in obesity or metabolic syndrome remains to be explored.
Blood samples were obtained from women with obesity before and after three-months supplementation with a moderate dose of n-3 PUFAs (1.8 g EPA + DHA per day) or from controls. n-3 PUFAs (GC) and plasma concentrations of lipoxins, resolvins, protectin X (GC-MS/MS) and inflammatory markers (ELISA) were measured. Whole blood transcriptome was assayed using microarray.
Women supplemented with n-3 PUFAs for 3 months had significantly higher levels of EPA and DHA in plasma phosphatidylcholine. n-3 PUFA supplementation, in contrast to placebo, significantly decreased the concentrations of several inflammatory markers (SELE, MCP-1, sVCAM-1, sPECAM-1, and hsCRP), fasting triglycerides and insulin and increased the concentrations of pro-resolving DHA derivatives in plasma. The microarray data demonstrated effects of n-3 PUFAs on PPAR-?, NRF2 and NF-?B target genes.
N-3 PUFAs increased DHA-derived pro-resolving mediators in women with obesity. Elevated resolvins and up-regulation of the resolvin receptor occurred in parallel with activation of PPAR-? target genes related to lipid metabolism and of NRF2 up-regulated antioxidant enzymes.
Text
__soton.ac.uk_ude_PersonalFiles_Users_lce_mydocuments_Eprints - Prof Calder_Accepted publications for eprints_BBALIP-16-27R2-1 corr2.pdf
- Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
Prof Calder_Accepted publications for eprints_15_NUT-D-16-00035R2.pdf
- Accepted Manuscript
More information
Accepted/In Press date: 10 August 2016
e-pub ahead of print date: 12 August 2016
Published date: 12 August 2016
Organisations:
Faculty of Medicine, Human Development & Health
Identifiers
Local EPrints ID: 399416
URI: http://eprints.soton.ac.uk/id/eprint/399416
ISSN: 1388-1981
PURE UUID: 128a1193-9292-4a84-8ca7-4a42cf678126
Catalogue record
Date deposited: 16 Aug 2016 12:57
Last modified: 15 Mar 2024 05:48
Export record
Altmetrics
Contributors
Author:
A. Polus
Author:
B. Zapala
Author:
U. Razny
Author:
A. Gielicz
Author:
B. Kiec-Wilk
Author:
M. Malczewska-Malec
Author:
M. Sanak
Author:
A. Dembinska-Kiec
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
